RealClear Markets: The Direct Route to Cheaper Pharmaceutical Drugs ByJustin Leventhal October 30, 2025October 30, 2025
How a Drug Discount Program Became a Hospital Profit Center ByJustin Leventhal October 23, 2025October 23, 2025
RealClear Markets: Why Is the FDA Easier on Cigarettes Than Smoking Cessation Tools? ByJustin Leventhal October 23, 2025October 23, 2025
RealClear Markets: Let Drug Buyers See the Books of Pharmacy Benefit Managers ByJustin Leventhal October 22, 2025October 22, 2025
DC Journal: The FDA and PBMs Are Blocking Cheap Biologics ByJustin Leventhal October 15, 2025October 15, 2025
RealClear Markets: Tariffs Don’t Build Factories, They Make Patients Pay More ByJustin Leventhal October 7, 2025October 7, 2025
DC Journal: How Rich Hospitals Hijacked a Drug Program for the Poor ByJustin Leventhal October 6, 2025October 6, 2025
First, Do No Harm: How California Chatbot Regulation Threatens Mental Health ByLogan Kolas and Pablo Garcia Quint September 30, 2025September 30, 2025
